BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16787344)

  • 21. A kit method for the high level synthesis of [211At]MABG.
    Vaidyanathan G; Affleck DJ; Alston KL; Zhao XG; Hens M; Hunter DH; Babich J; Zalutsky MR
    Bioorg Med Chem; 2007 May; 15(10):3430-6. PubMed ID: 17387017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of meta-[211At]astatobenzylguanidine in an athymic mouse human neuroblastoma xenograft model.
    Vaidyanathan G; Friedman HS; Keir ST; Zalutsky MR
    Nucl Med Biol; 1996 Aug; 23(6):851-6. PubMed ID: 8940730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced tumour uptake and in vitro radiotoxicity of no-carrier-added [131I]meta-iodobenzylguanidine: implications for the targeted radiotherapy of neuroblastoma.
    Mairs RJ; Russell J; Cunningham S; O'Donoghue JA; Gaze MN; Owens J; Vaidyanathan G; Zalutsky MR
    Eur J Cancer; 1995; 31A(4):576-81. PubMed ID: 7576972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of poly(ADP-Ribose) polymerase enhances the toxicity of 131I-metaiodobenzylguanidine/topotecan combination therapy to cells and xenografts that express the noradrenaline transporter.
    McCluskey AG; Mairs RJ; Tesson M; Pimlott SL; Babich JW; Gaze MN; Champion S; Boyd M
    J Nucl Med; 2012 Jul; 53(7):1146-54. PubMed ID: 22689924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted radiotherapy of multicell neuroblastoma spheroids with high specific activity [125I]meta-iodobenzylguanidine.
    Roa WH; Miller GG; McEwan AJ; McQuarrie SA; Tse J; Wu J; Wiebe LI
    Int J Radiat Oncol Biol Phys; 1998 May; 41(2):425-32. PubMed ID: 9607361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo evaluation of a cancer therapy strategy combining HSV1716-mediated oncolysis with gene transfer and targeted radiotherapy.
    Sorensen A; Mairs RJ; Braidwood L; Joyce C; Conner J; Pimlott S; Brown M; Boyd M
    J Nucl Med; 2012 Apr; 53(4):647-54. PubMed ID: 22414636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transfectant mosaic spheroids: a new model for evaluation of tumour cell killing in targeted radiotherapy and experimental gene therapy.
    Boyd M; Mairs SC; Stevenson K; Livingstone A; Clark AM; Ross SC; Mairs RJ
    J Gene Med; 2002; 4(5):567-76. PubMed ID: 12221650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific binding and uptake of 131I-MIBG and 111In-octreotide in metastatic paraganglioma--tools for choice of radionuclide therapy.
    Spetz J; Dalmo J; Nilsson O; Wängberg B; Ahlman H; Forssell-Aronsson E
    Horm Metab Res; 2012 May; 44(5):400-4. PubMed ID: 22566195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the therapeutic efficacy of 211At- and 131I-labelled monoclonal antibody MOv18 in nude mice with intraperitoneal growth of human ovarian cancer.
    Andersson H; Palm S; Lindegren S; Bäck T; Jacobsson L; Leser G; Horvath G
    Anticancer Res; 2001; 21(1A):409-12. PubMed ID: 11299770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved effect of 131I-MIBG treatment by predosing with non-radiolabeled MIBG in carcinoid patients, and studies in xenografted mice.
    Taal BG; Hoefnagel C; Boot H; Valdés Olmos R; Rutgers M
    Ann Oncol; 2000 Nov; 11(11):1437-43. PubMed ID: 11142484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A gene therapy approach to enhance the targeted radiotherapy of neuroblastoma.
    Cunningham S; Boyd M; Brown MM; Carlin S; McCluskey A; Livingstone A; Mairs RJ; Wheldon TE
    Med Pediatr Oncol; 2000 Dec; 35(6):708-11. PubMed ID: 11107152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted therapy using alpha emitters.
    Vaidyanathan G; Zalutsky MR
    Phys Med Biol; 1996 Oct; 41(10):1915-31. PubMed ID: 8912371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ¹¹¹In-DTPA⁰-octreotide (Octreoscan), ¹³¹I-MIBG and other agents for radionuclide therapy of NETs.
    Bomanji JB; Papathanasiou ND
    Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S113-25. PubMed ID: 22388626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting of meta-iodobenzylguanidine to SK-N-SH human neuroblastoma xenografts: tissue distribution, metabolism and therapeutic efficacy.
    Rutgers M; Buitenhuis CK; Hoefnagel CA; Voûte PA; Smets LA
    Int J Cancer; 2000 Aug; 87(3):412-22. PubMed ID: 10897048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cotransfecting norepinephrine transporter and vesicular monoamine transporter 2 genes for increased retention of metaiodobenzylguanidine labeled with iodine 131 in malignant hepatocarcinoma cells.
    Zhao Y; Zhong X; Ou X; Cai H; Wu X; Huang R
    Front Med; 2017 Mar; 11(1):120-128. PubMed ID: 28213878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organic cation transporter 3 mediates the non-norepinephrine transporter driven uptake of meta-[
    Ohshima Y; Sasaki I; Watanabe S; Sakashita T; Higashi T; Ishioka NS
    Nucl Med Biol; 2022; 112-113():44-51. PubMed ID: 35802985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No-carrier-added 123I-MIBG: an initial clinical study in patients with phaeochromocytoma.
    Owens J; Bolster AA; Prosser JE; Cunningham S; Mairs RJ; Neilly JB; Reed NS; Hilditch TE
    Nucl Med Commun; 2000 May; 21(5):437-40. PubMed ID: 10874700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implications of the uptake of 131I-radiolabelled meta-iodobenzylguanidine (mIBG) for the targeted radiotherapy of neuroblastoma.
    O'Donoghue JA; Wheldon TE; Babich JW; Moyes JS; Barrett A; Meller ST
    Br J Radiol; 1991 May; 64(761):428-34. PubMed ID: 2036567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased MIBG uptake after transfer of the human norepinephrine transporter gene in rat hepatoma.
    Altmann A; Kissel M; Zitzmann S; Kübler W; Mahmut M; Peschke P; Haberkorn U
    J Nucl Med; 2003 Jun; 44(6):973-80. PubMed ID: 12791828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo studies with no-carrier added radioiodinated MIBG.
    Franceschini R; Pecorale A; Chinol M; Calcagni ML; Servidei T; Riccardi R; Troncone L
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):72-7. PubMed ID: 9002755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.